Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.0.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Jun. 30, 2021
Current assets:    
Cash $ 794,502 $ 1,041,899
Accounts receivable – net 60,679 109,589
Inventories 425,331 387,736
Other current assets 119,093 33,480
Total current assets 1,399,605 1,572,704
Total assets 1,399,605 1,572,704
Current liabilities:    
Accounts payable 257,802 459,703
Accrued expense-related party   3,000
Convertible notes payable – net of discount 80,946  
Total current liabilities 338,748 462,703
Commitments and contingencies
Stockholders’ equity:    
Series A Stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of December 31, 2021 and June 30, 2021, respectively) 1 1
Series B Stock, ($0.001 par value, 5,000 shares authorized, and 3,835 and 4,665 issued and outstanding as of December 31, 2021 and June 30, 2021, respectively) 4 5
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 87,060,178 issued and outstanding as of December 31, 2021 and 80,707,467 issued and outstanding as of June 30, 2021, respectively) 87,060 80,707
Additional paid in capital 28,143,914 26,226,159
Accumulated deficit (27,170,122) (25,196,871)
Total stockholders’ equity 1,060,857 1,110,001
Total liabilities and stockholders’ equity $ 1,399,605 $ 1,572,704